| May 12, 2003 | |||||||||
In Print![]() Photo by Steve Gilbert
Focus: Antibodies dispersed by B lymphocytes learn where and how to fight pathogens by genetic changes known as class switch recombination. Two studies from Frederick Alt's lab show the first steps in a crucial enzyme's genetic modification of the switch region, which customizes the end of the antibody gene and determines how the antibody will mount its defense. When the mechanism goes awry, it may contribute to some cancers.
|
|
HeadlinesMedicare Patients in Managed Care Programs More Likely to Use Hospice Care Researchers Identify Important Function of NF2 Tumor Suppressor
UpcomingAIDS Symposium:Harvard Programs on AIDS and Global Health: Drugs for Prevention and Treatment
Several presenters
Lab WorksA multimedia site featuring Harvard Medical research |
Spotlight
Student Scene
|
||||||
Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home |